Lab-Made Meat Startup SuperMeat raises $3M Seed to develop ‘Clean’ Chicken
SuperMeat, an Israeli biotech and food-tech startup that is developing lab-made chicken meat, raised early this year $3 million in seed funding, as it becomes
Cellect Signs Strategic Agreement with Swiss Biotech Center (SBC) & with Dresden University denovoMATRIX Team
Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced that it has entered into a strategic manufacturing and supply agreement
Oramed to be Added to Russell Microcap® Index
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it
Prince William Experiences Orcam’s Life Changing Device for Blind People
Prince William, the Duke of Cambridge, has made a truly historic first official visit of a member of the Royal Family to Israel. Yesterday, June
Mazor Robotics’ Renaissance System installed at Georgia ASC and at Advocate Lutheran General Hospital in Illinois
In June 2018, GNS Surgery Center, an affiliate of United Surgical Partners International, announced that it has completed their first procedure with the Mazor Robotics
Jerusalem based Entera Bio Ltd. Announces Pricing of IPO for conducting Clinical Trials of Three Orally delivered Drugs targeting the Gastrointestinal Tract
Entera Bio Ltd. (NASDAQ:ENTX) (NASDAQ:ENTXW), a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics and is conducting clinical
Kadimastem has Upgraded its Manufacturing Site for Treatment of ALS Patients in the Clinical Trial
Kadimastem chose to upgrade the production rooms, for the treatment of ALS patients in the Phase 1 / 2a clinical trial, and adapt them to
HIL Co-Founder and CTO, Prof. Arie Zigler, is a finalist for Berthold Leibinger Innovationspreis 2018
June, 2018 – Prof. Arie Zigler, HIL’s Co-Founder and CTO, and a faculty member of the Hebrew University’s Physics Department, was announced as a finalist
Ayala Pharmaceuticals Presents Phase 1b Data at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting for AL101, a Pan-Notch Inhibitor, in Patients with Locally Advanced or Metastatic Solid Tumors
Positive Results Support Development Pathway of AL101 as a Targeted Therapy for Patients with Tumors That Have Activating Notch Mutations Ayala Pharmaceuticals, a clinical stage
